These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 30773852)

  • 21. Aberrant posttranscriptional processing of hyaluronan synthase 1 in malignant transformation and tumor progression.
    Adamia S; Kriangkum J; Belch AR; Pilarski LM
    Adv Cancer Res; 2014; 123():67-94. PubMed ID: 25081526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of alternative mRNA splicing: old players and new perspectives.
    Dvinge H
    FEBS Lett; 2018 Sep; 592(17):2987-3006. PubMed ID: 29856907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alternative RNA splicing in tumour heterogeneity, plasticity and therapy.
    Öther-Gee Pohl S; Myant KB
    Dis Model Mech; 2022 Jan; 15(1):. PubMed ID: 35014671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Oncogenic transcription factors as splicing regulators].
    Théoleyre O; Baklouti F
    Med Sci (Paris); 2004 Nov; 20(11):1014-9. PubMed ID: 15525498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers.
    Cohen-Eliav M; Golan-Gerstl R; Siegfried Z; Andersen CL; Thorsen K; Ørntoft TF; Mu D; Karni R
    J Pathol; 2013 Mar; 229(4):630-9. PubMed ID: 23132731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pre-mRNA alternative splicing in cancer: functional impact, molecular mechanisms and therapeutic perspectives].
    Revil T; Shkreta L; Chabot B
    Bull Cancer; 2006 Sep; 93(9):909-19. PubMed ID: 16980234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulatory RNA binding proteins contribute to the transcriptome-wide splicing alterations in human cellular senescence.
    Dong Q; Wei L; Zhang MQ; Wang X
    Aging (Albany NY); 2018 Jun; 10(6):1489-1505. PubMed ID: 29936497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of the splicing factor SRSF4 in cisplatin-induced modifications of pre-mRNA splicing and apoptosis.
    Gabriel M; Delforge Y; Deward A; Habraken Y; Hennuy B; Piette J; Klinck R; Chabot B; Colige A; Lambert C
    BMC Cancer; 2015 Apr; 15():227. PubMed ID: 25884497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aberrant splicing, hyaluronan synthases and intracellular hyaluronan as drivers of oncogenesis and potential drug targets.
    Adamia S; Pilarski PM; Belch AR; Pilarski LM
    Curr Cancer Drug Targets; 2013 May; 13(4):347-61. PubMed ID: 23517594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alternative splicing in cancer: noise, functional, or systematic?
    Skotheim RI; Nees M
    Int J Biochem Cell Biol; 2007; 39(7-8):1432-49. PubMed ID: 17416541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SR protein kinases: the splice of life.
    Stojdl DF; Bell JC
    Biochem Cell Biol; 1999; 77(4):293-8. PubMed ID: 10546892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From General Aberrant Alternative Splicing in Cancers and Its Therapeutic Application to the Discovery of an Oncogenic DMTF1 Isoform.
    Tian N; Li J; Shi J; Sui G
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28257090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell survival: Interplay between hypoxia and pre-mRNA splicing.
    Kanopka A
    Exp Cell Res; 2017 Jul; 356(2):187-191. PubMed ID: 28315669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alternative Splicing of hTERT Pre-mRNA: A Potential Strategy for the Regulation of Telomerase Activity.
    Liu X; Wang Y; Chang G; Wang F; Wang F; Geng X
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28272339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel mechanism of aberrant pre-mRNA splicing in humans.
    Cogan JD; Prince MA; Lekhakula S; Bundey S; Futrakul A; McCarthy EM; Phillips JA
    Hum Mol Genet; 1997 Jun; 6(6):909-12. PubMed ID: 9175738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Perspectives of RNA interference application in the therapy of diseases associated with defects in alternative RNA splicing].
    Wysokiński D; Błasiak J
    Postepy Hig Med Dosw (Online); 2012 Sep; 66():683-95. PubMed ID: 23001210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A saga of cancer epigenetics: linking epigenetics to alternative splicing.
    Narayanan SP; Singh S; Shukla S
    Biochem J; 2017 Mar; 474(6):885-896. PubMed ID: 28270561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Towards understanding pre-mRNA splicing mechanisms and the role of SR proteins.
    Sahebi M; Hanafi MM; van Wijnen AJ; Azizi P; Abiri R; Ashkani S; Taheri S
    Gene; 2016 Aug; 587(2):107-19. PubMed ID: 27154819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of viral splicing elements and cellular RNA binding proteins in regulation of HIV-1 alternative RNA splicing.
    Stoltzfus CM; Madsen JM
    Curr HIV Res; 2006 Jan; 4(1):43-55. PubMed ID: 16454710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pre-mRNA splicing aberrations and cancer.
    Pettigrew CA; Brown MA
    Front Biosci; 2008 Jan; 13():1090-105. PubMed ID: 17981615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.